Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other financing activities (2016 - 2021)

Medifast (MED) has disclosed Other financing activities for 12 consecutive years, with $34000.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Other financing activities fell 5.56% year-over-year to $34000.0, compared with a TTM value of $1.9 million through Sep 2021, up 233.81%, and an annual FY2020 reading of $551000.0, down 96.09% over the prior year.
  • Other financing activities was $34000.0 for Q3 2021 at Medifast, up from $26000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.2 million in Q4 2017 and bottomed at $9000.0 in Q2 2020.
  • Average Other financing activities over 5 years is $372937.5, with a median of $35000.0 recorded in 2018.
  • The sharpest move saw Other financing activities surged 1649.6% in 2017, then tumbled 78.46% in 2018.
  • Year by year, Other financing activities stood at $2.2 million in 2017, then crashed by 78.46% to $471000.0 in 2018, then tumbled by 92.99% to $33000.0 in 2019, then crashed by 42.42% to $19000.0 in 2020, then skyrocketed by 78.95% to $34000.0 in 2021.
  • Business Quant data shows Other financing activities for MED at $34000.0 in Q3 2021, $26000.0 in Q2 2021, and $1.8 million in Q1 2021.